Literature DB >> 18981890

Advanced magnetic resonance imaging of cerebral cavernous malformations: part I. High-field imaging of excised human lesions.

Robert Shenkar1, Palamadai N Venkatasubramanian, Jin-cheng Zhao, H Hunt Batjer, Alice M Wyrwicz, Issam A Awad.   

Abstract

OBJECTIVE: We hypothesized that structural details that have not been described previously would be revealed in cerebral cavernous malformations (CCM) through the use of high-field magnetic resonance and confocal microscopy. The structural details of CCMs excised from patients were sought by examination with high-field magnetic resonance imaging (MRI) and correlated with confocal microscopy of the same specimens. Novel features of CCM structure are outlined, including methodological limitations, venues for future research, and possible clinical implications.
METHODS: CCM lesions excised from 4 patients were fixed in 2% paraformaldehyde and subjected to high-resolution MRI at 9.4 or 14.1-T by spin echo and gradient recalled echo methods. Histological validation of angioarchitecture was conducted on thick sections of CCM lesions using fluorescent probes to endothelium under confocal microscopy.
RESULTS: Images of excised human CCM lesions were acquired with proton density-weighted, T1-weighted, T2-weighted spin echo, and T2*-weighted gradient recalled echo MRI. These images revealed large "bland" regions with thin-walled caverns and "honeycombed" regions with notable capillary proliferation and smaller caverns surrounding larger caverns. Proliferating capillaries and caverns of various sizes were also associated with the walls of apparent larger blood vessels in the lesions. Similar features were confirmed within thick sections of CCMs by confocal microscopy. MRI relaxation times in different regions of interest suggested the presence of different states of blood breakdown products in areas with apparent angiogenic proliferative activity.
CONCLUSION: High-field MRI techniques demonstrate novel features of CCM angioarchitecture, visible at near histological resolution, including regions with apparently different biological activity. These preliminary observations will motivate future research, correlating lesion biological and clinical activity with features of MRI at higher field strength.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18981890      PMCID: PMC2615642          DOI: 10.1227/01.NEU.0000325490.80694.A2

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  31 in total

1.  Ultrastructural pathological features of cerebrovascular malformations: a preliminary report.

Authors:  J H Wong; I A Awad; J H Kim
Journal:  Neurosurgery       Date:  2000-06       Impact factor: 4.654

2.  Measurements of T1 and T2 over time in formalin-fixed human whole-brain specimens.

Authors:  M Tovi; A Ericsson
Journal:  Acta Radiol       Date:  1992-09       Impact factor: 1.990

Review 3.  Developmental venous anomalies and cavernous angiomas: a review of the concurrence, imaging, and treatment of these vascular malformations.

Authors:  Douglas P Beall; Jayson P Bell; James R Webb; Jon R Fish
Journal:  J Okla State Med Assoc       Date:  2005-11

4.  Magnetic resonance imaging and mathematical modeling of progressive formalin fixation of the human brain.

Authors:  Charlotte J Yong-Hing; Andre Obenaus; Rodrick Stryker; Karen Tong; Gordon E Sarty
Journal:  Magn Reson Med       Date:  2005-08       Impact factor: 4.668

5.  The role of small angiomatous malformations in the production of intracerebral hematomas.

Authors:  G MARGOLIS; G L ODOM; B WOODHALL; B M BLOOR
Journal:  J Neurosurg       Date:  1951-11       Impact factor: 5.115

Review 6.  [131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies].

Authors:  P Otten; G P Pizzolato; B Rilliet; J Berney
Journal:  Neurochirurgie       Date:  1989       Impact factor: 1.553

7.  The MRI appearance of cavernous malformations (angiomas).

Authors:  D Rigamonti; B P Drayer; P C Johnson; M N Hadley; J Zabramski; R F Spetzler
Journal:  J Neurosurg       Date:  1987-10       Impact factor: 5.115

8.  Vascular smooth muscle cell differentiation in human cerebral vascular malformations.

Authors:  R Uranishi; N I Baev; J H Kim; I A Awad
Journal:  Neurosurgery       Date:  2001-09       Impact factor: 4.654

Review 9.  A brainstem cavernoma demonstrating a dramatic, spontaneous decrease in size during follow-up: case report and review of the literature.

Authors:  Toshihiro Yasui; Masaki Komiyama; Yoshiyasu Iwai; Kazuhiro Yamanaka; Yasuhiro Matsusaka; Toshie Morikawa; Tomoya Ishiguro
Journal:  Surg Neurol       Date:  2005-02

10.  Value of gradient-echo magnetic resonance imaging in the diagnosis of familial cerebral cavernous malformation.

Authors:  Fritz-Georg Lehnhardt; Ulrich von Smekal; Benedikt Rückriem; Werner Stenzel; Michael Neveling; Wolf-Dieter Heiss; Andreas H Jacobs
Journal:  Arch Neurol       Date:  2005-04
View more
  12 in total

1.  Mutations of RNF213 are responsible for sporadic cerebral cavernous malformation and lead to a mulberry-like cluster in zebrafish.

Authors:  Jing Lin; Jie Liang; Jun Wen; Man Luo; Jiaoxing Li; Xunsha Sun; Xiaowei Xu; Jianli Li; Dongxian Wang; Jie Wang; Huimin Chen; Rong Lai; Fengyin Liang; Chuan Li; Fei Ye; Jingjing Zhang; Jinsheng Zeng; Shulan Yang; Wenli Sheng
Journal:  J Cereb Blood Flow Metab       Date:  2020-04-04       Impact factor: 6.200

2.  Evaluation of iron content in human cerebral cavernous malformation using quantitative susceptibility mapping.

Authors:  Huan Tan; Tian Liu; Ying Wu; Jon Thacker; Robert Shenkar; Abdul Ghani Mikati; Changbin Shi; Conner Dykstra; Yi Wang; Pottumarthi V Prasad; Robert R Edelman; Issam A Awad
Journal:  Invest Radiol       Date:  2014-07       Impact factor: 6.016

Review 3.  CCM1 and the second life of proteins in adhesion complexes.

Authors:  Maaike C W van den Berg; Boudewijn M T Burgering
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

4.  Quantitative Susceptibility Mapping in Cerebral Cavernous Malformations: Clinical Correlations.

Authors:  H Tan; L Zhang; A G Mikati; R Girard; O Khanna; M D Fam; T Liu; Y Wang; R R Edelman; G Christoforidis; I A Awad
Journal:  AJNR Am J Neuroradiol       Date:  2016-03-10       Impact factor: 3.825

Review 5.  Emerging clinical imaging techniques for cerebral cavernous malformations: a systematic review.

Authors:  Peter G Campbell; Pascal Jabbour; Sanjay Yadla; Issam A Awad
Journal:  Neurosurg Focus       Date:  2010-09       Impact factor: 4.047

6.  PDCD10 (CCM3) regulates brain endothelial barrier integrity in cerebral cavernous malformation type 3: role of CCM3-ERK1/2-cortactin cross-talk.

Authors:  Svetlana M Stamatovic; Nikola Sladojevic; Richard F Keep; Anuska V Andjelkovic
Journal:  Acta Neuropathol       Date:  2015-09-18       Impact factor: 17.088

7.  Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.

Authors:  Rebecca A Stockton; Robert Shenkar; Issam A Awad; Mark H Ginsberg
Journal:  J Exp Med       Date:  2010-03-22       Impact factor: 14.307

8.  KRIT1 regulates the homeostasis of intracellular reactive oxygen species.

Authors:  Luca Goitre; Fiorella Balzac; Simona Degani; Paolo Degan; Saverio Marchi; Paolo Pinton; Saverio Francesco Retta
Journal:  PLoS One       Date:  2010-07-26       Impact factor: 3.240

Review 9.  Recent insights into cerebral cavernous malformations: animal models of CCM and the human phenotype.

Authors:  Aubrey C Chan; Dean Y Li; Michel J Berg; Kevin J Whitehead
Journal:  FEBS J       Date:  2010-01-22       Impact factor: 5.542

Review 10.  7T Epilepsy Task Force Consensus Recommendations on the Use of 7T MRI in Clinical Practice.

Authors:  Giske Opheim; Anja van der Kolk; Karin Markenroth Bloch; Albert J Colon; Kathryn A Davis; Thomas R Henry; Jacobus F A Jansen; Stephen E Jones; Jullie W Pan; Karl Rössler; Joel M Stein; Maria C Strandberg; Siegfried Trattnig; Pierre-Francois Van de Moortele; Maria Isabel Vargas; Irene Wang; Fabrice Bartolomei; Neda Bernasconi; Andrea Bernasconi; Boris Bernhardt; Isabella Björkman-Burtscher; Mirco Cosottini; Sandhitsu R Das; Lucie Hertz-Pannier; Sara Inati; Michael T Jurkiewicz; Ali R Khan; Shuli Liang; Ruoyun Emily Ma; Srinivasan Mukundan; Heath Pardoe; Lars H Pinborg; Jonathan R Polimeni; Jean-Philippe Ranjeva; Esther Steijvers; Steven Stufflebeam; Tim J Veersema; Alexandre Vignaud; Natalie Voets; Serge Vulliemoz; Christopher J Wiggins; Rong Xue; Renzo Guerrini; Maxime Guye
Journal:  Neurology       Date:  2020-12-22       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.